(Q46840298)

English

Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094666%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094666%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

based on heuristic

inferred from title

Joshua S Rodefer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094666%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Tuyet N Nguyen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094666%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Jens-Jakob Karlsson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094666%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Jørn Arnt

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094666%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

0 references

publication date

19 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094666%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094666%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094666%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094666%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

2657-2666

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18094666%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301654

0 references

Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Neurocognitive and social functioning in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Aged rats are impaired on an attentional set-shifting task sensitive to medial frontal cortex damage in young rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Do clozapine and risperidone affect social competence and problem solving?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set-shifting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Do neuroleptics impair learning in schizophrenic patients?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Dissociation in prefrontal cortex of affective and attentional shifts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Effects of antipsychotics on cognitive behaviour in rats using the delayed non-match to position paradigm.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Sertindole, in contrast to clozapine and olanzapine, does not disrupt water maze performance after acute or chronic treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Cognition, drug treatment, and functional outcome in schizophrenia: a tale of two transitions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

What are the functional consequences of neurocognitive deficits in schizophrenia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Sertindole (Serdolect): preclinical and clinical findings of a new atypical antipsychotic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

5‐HT6 receptor antagonist SB‐271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

5-HT6 receptors: a novel target for cognitive enhancement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Cognitive function in schizophrenia--do neuroleptics make a difference?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

5-ht6 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

21 January 2018

Medial frontal cortex mediates perceptual attentional set shifting in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroleptic drug effects on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

7 January 2021

based on heuristic

inferred from DOI database lookup

Perceptual attentional set-shifting is impaired in rats with neurotoxic lesions of posterior parietal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

7 January 2021

based on heuristic

inferred from DOI database lookup

Convergence of cognitive and adaptive decline in late-life schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

7 January 2021

based on heuristic

inferred from DOI database lookup

Naltrexone reverses age-induced cognitive deficits in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vivo assessment of 5-HT2A and 5-HT2C antagonistic properties of newer antipsychotics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

7 January 2021

based on heuristic

inferred from DOI database lookup

Cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301654

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46840298&oldid=1975558420"